Dupont Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
FAM
CIP
FLAM
CS
Dupont Capital Management's ATRC Position: Q2 2022 in Review
Dupont Capital Management sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 9,039 shares — an estimated $594K sold.
Dupont Capital Management first reported a position in ATRC in Q4 2019 and held it in 10 quarters. The position peaked at $1.49M in Q1 2020. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.
- Dupont Capital Management reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
- Dupont Capital Management sold 9,039 AtriCure shares in Q2 2022, an estimated $594K.
- Dupont Capital Management first reported a position in AtriCure in Q4 2019 and held it in 10 quarters.
- Dupont Capital Management's AtriCure position peaked at $1.49M in Q1 2020.
- 213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.
Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.